» Articles » PMID: 17706958

Multiple Cardiovascular Defects Caused by the Absence of Alternatively Spliced Segments of Fibronectin

Overview
Journal Dev Biol
Publisher Elsevier
Date 2007 Aug 21
PMID 17706958
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Alternatively spliced variants of fibronectin (FN) containing exons EIIIA and EIIIB are expressed around newly forming vessels in development and disease but are downregulated in mature vasculature. The sequences and patterns of expression of these splice variants are highly conserved among vertebrates, suggestive of their biological importance; however the functions of EIIIA and EIIIB-containing FNs are unknown. To understand the role(s) of these splice variants, we deleted both EIIIA and EIIIB exons from the FN gene and observed embryonic lethality with incomplete penetrance by embryonic day 10.5. Deletion of both EIIIA and EIIIB exons did not affect synthesis or cell surface deposition of FN, indicating that embryonic lethality was due specifically to the absence of EIIIA and EIIIB exons from FN. EIIIA/EIIIB double-null embryos displayed multiple embryonic cardiovascular defects, including vascular hemorrhage, failure of remodeling embryonic and yolk sac vasculature, defective placental angiogenesis and heart defects. In addition, we observed defects in coverage and association with dorsal aortae of alpha-smooth-muscle-actin-positive cells. Our studies indicate that the presence or absence of EIIIA and EIIIB exons alters the function of FN and demonstrate the requirement for these alternatively spliced exons in cardiovascular development.

Citing Articles

Mutations in fibronectin dysregulate chondrogenesis in skeletal dysplasia.

Dinesh N, Rousseau J, Mosher D, Strauss M, Mui J, Campeau P Cell Mol Life Sci. 2024; 81(1):419.

PMID: 39367925 PMC: 11456097. DOI: 10.1007/s00018-024-05444-4.


Cell diversity and plasticity during atrioventricular heart valve EMTs.

Lotto J, Cullum R, Drissler S, Arostegui M, Garside V, Fuglerud B Nat Commun. 2023; 14(1):5567.

PMID: 37689753 PMC: 10492828. DOI: 10.1038/s41467-023-41279-6.


Treating solid tumors with TCR-based chimeric antigen receptor targeting extra domain B-containing fibronectin.

Zhang Z, Liu C, Wang M, Sun R, Yang Z, Hua Z J Immunother Cancer. 2023; 11(8).

PMID: 37586774 PMC: 10432677. DOI: 10.1136/jitc-2023-007199.


Molecular Motifs in Vascular Morphogenesis: Vascular Endothelial Growth Factor A (VEGFA) as the Leading Promoter of Angiogenesis.

Lungu C, Mehedinti M Int J Mol Sci. 2023; 24(15).

PMID: 37569543 PMC: 10418718. DOI: 10.3390/ijms241512169.


Extracellular Matrix Remodeling in Vascular Disease: Defining Its Regulators and Pathological Influence.

Lin P, Davis G Arterioscler Thromb Vasc Biol. 2023; 43(9):1599-1616.

PMID: 37409533 PMC: 10527588. DOI: 10.1161/ATVBAHA.123.318237.


References
1.
Kornblihtt A, Baralle F . Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J. 1984; 3(1):221-6. PMC: 557323. DOI: 10.1002/j.1460-2075.1984.tb01787.x. View

2.
Trachsel E, Kaspar M, Bootz F, Detmar M, Neri D . A human mAb specific to oncofetal fibronectin selectively targets chronic skin inflammation in vivo. J Invest Dermatol. 2006; 127(4):881-6. DOI: 10.1038/sj.jid.5700653. View

3.
Kornblihtt A, Umezawa K, Baralle F . Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 1985; 4(7):1755-9. PMC: 554414. DOI: 10.1002/j.1460-2075.1985.tb03847.x. View

4.
Liao Y, Gotwals P, Koteliansky V, Sheppard D, Van De Water L . The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem. 2002; 277(17):14467-74. DOI: 10.1074/jbc.M201100200. View

5.
Wijelath E, Murray J, Rahman S, Patel Y, Ishida A, Strand K . Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res. 2002; 91(1):25-31. DOI: 10.1161/01.res.0000026420.22406.79. View